Werner Lanthaler, Evotec CEO (via Argenx)

An 'in­ter­est­ing­ly porous' pouch: Two star­tups team up on a po­ten­tial­ly new way to treat di­a­betes

When Philip Toleikis joined Ser­no­va in 2009, he en­vi­sioned his com­pa­ny’s cell pouch de­vice would one day be used with stem cells, a field which …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.